Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Ruff

Showing results (181-190 of 224) with videos related to

Pageof 23
Sort By:
Circulation|January 24, 2024
Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial FibrillationSiddharth M Patel, Eugene Braunwald, Jan Steffel, et al.
European Journal of Preventive Cardiology|October 28, 2025
Polygenic Risk Score for Coronary Artery Disease Across the Spectrum of Atherosclerotic DiseaseAndre Zimerman, Frederick K Kamanu, Giorgio E M Melloni, et al.
Nature Medicine|August 6, 2024
Clonal hematopoiesis, cardiovascular events and treatment benefit in 63,700 individuals from five TIMI randomized trialsNicholas A Marston, James P Pirruccello, Giorgio E M Melloni, et al.
JAMA|September 3, 2019
Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular DiseaseBrian A Ference, Deepak L Bhatt, Alberico L Catapano, et al.
Journal of the American College of Cardiology|June 11, 2025
Long-Acting Factor XI Inhibition and Periprocedural Bleeding: An Analysis From AZALEA-TIMI 71Siddharth M Patel, Robert P Giugliano, David A Morrow, et al.
Journal of the American College of Cardiology|August 6, 2025
Outcomes in Older Patients After Switching to a Newer Anticoagulant or Remaining on Warfarin: The COMBINE-AF SubstudyAndre M Nicolau, Robert P Giugliano, Andre Zimerman, et al.
European Heart Journal|November 28, 2025
A polygenic risk score for peripheral artery disease and major adverse limb eventsSamer Al Said, Siddharth M Patel, Giorgio E M Melloni, et al.
The New England Journal of Medicine|January 22, 2025
Abelacimab versus Rivaroxaban in Patients with Atrial FibrillationChristian T Ruff, Siddharth M Patel, Robert P Giugliano, et al.
Circulation|December 28, 2018
Lorcaserin and Renal Outcomes in Obese and Overweight Patients in the CAMELLIA-TIMI 61 TrialBenjamin M Scirica, Erin A Bohula, Jamie P Dwyer, et al.
Nature Reviews. Cardiology|March 31, 2025
Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolismDavide Capodanno, John H Alexander, M Cecilia Bahit, et al.
Pageof 23

Showing results (181-190 of 224) with videos related to

Sort By:
Pageof 23
Circulation|January 24, 2024
Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial FibrillationSiddharth M Patel, Eugene Braunwald, Jan Steffel, et al.
European Journal of Preventive Cardiology|October 28, 2025
Polygenic Risk Score for Coronary Artery Disease Across the Spectrum of Atherosclerotic DiseaseAndre Zimerman, Frederick K Kamanu, Giorgio E M Melloni, et al.
Nature Medicine|August 6, 2024
Clonal hematopoiesis, cardiovascular events and treatment benefit in 63,700 individuals from five TIMI randomized trialsNicholas A Marston, James P Pirruccello, Giorgio E M Melloni, et al.
JAMA|September 3, 2019
Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular DiseaseBrian A Ference, Deepak L Bhatt, Alberico L Catapano, et al.
Journal of the American College of Cardiology|June 11, 2025
Long-Acting Factor XI Inhibition and Periprocedural Bleeding: An Analysis From AZALEA-TIMI 71Siddharth M Patel, Robert P Giugliano, David A Morrow, et al.
Journal of the American College of Cardiology|August 6, 2025
Outcomes in Older Patients After Switching to a Newer Anticoagulant or Remaining on Warfarin: The COMBINE-AF SubstudyAndre M Nicolau, Robert P Giugliano, Andre Zimerman, et al.
European Heart Journal|November 28, 2025
A polygenic risk score for peripheral artery disease and major adverse limb eventsSamer Al Said, Siddharth M Patel, Giorgio E M Melloni, et al.
The New England Journal of Medicine|January 22, 2025
Abelacimab versus Rivaroxaban in Patients with Atrial FibrillationChristian T Ruff, Siddharth M Patel, Robert P Giugliano, et al.
Circulation|December 28, 2018
Lorcaserin and Renal Outcomes in Obese and Overweight Patients in the CAMELLIA-TIMI 61 TrialBenjamin M Scirica, Erin A Bohula, Jamie P Dwyer, et al.
Nature Reviews. Cardiology|March 31, 2025
Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolismDavide Capodanno, John H Alexander, M Cecilia Bahit, et al.
Pageof 23